67th American Society of Hematology Annual Meeting and Exposition (ASH 2025)
Orlando, Florida, US 06 December 2025 - 09 December 2025
IV iron lowers mortality risk in anaemics
A retrospective study spanning 25 years has shown that intravenous (IV) iron therapy in hospitalized patients with iron-deficiency anaemia and acute infections is associated with a lower risk of death.
IV iron lowers mortality risk in anaemics
5 hours ago
Does aspirin use improve outcomes in APS patients with arterial thrombosis?
The addition of low-dose aspirin to warfarin appears to increase the risk of major bleeding in patients with antiphospholipid syndrome (APS) but falls short in reducing all-cause mortality, according to a study presented at ASH 2025. Likewise, the rates of ischemic stroke and acute myocardial infarction are also higher among aspirin users.
Does aspirin use improve outcomes in APS patients with arterial thrombosis?
06 Jan 2026
Is there a link between IDA, cow’s milk intake, and bottle feeding?
A study from Canada demonstrates the burden of severe iron deficiency anaemia (IDA) among healthy children in the context of ongoing bottle feeding and excessive cow’s milk intake.
Is there a link between IDA, cow’s milk intake, and bottle feeding?
30 Dec 2025
Two DOACs show similar bleeding risks in head-to-head VTE trial
In a post hoc analysis of the RENOVE trial, the direct oral anticoagulants (DOACs) rivaroxaban and apixaban demonstrate comparable risks of clinically relevant bleeding (CRB) and recurrent venous thromboembolism (VTE). These were observed across the crude, adjusted, and IPTW* analyses.
